Home Page
Counties
Alachua
32608
MEDITRACE LLC

MEDITRACE LLC - Florida Company Profile

Is this your business?

Get access!

Company Details

Entity Name:	MEDITRACE LLC
Jurisdiction:	FLORIDA
Filing Type:	Florida Limited Liability Co. MEDITRACE LLC is structured as a Limited Liability Company (LLC), a common business structure that offers its members limited liability protection, separating their personal assets from the company's debts and obligations. In Florida, LLCs are governed by Title XXXVI, Chapter 605, Florida Revised Limited Liability Company Act
Status:	Active The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness.
Date Filed:	11 Mar 2016 (9 years ago)
Document Number:	L16000050948
FEI/EIN Number	81-1782420 Federal Employer Identification (FEI) Number assigned by the IRS.
Address:	3914 SW 95TH DRIVE, GAINESVILLE, FL, 32608
Mail Address:	3914 SW 95TH DRIVE, GAINESVILLE, FL, 32608
ZIP code:	32608
County:	Alachua
Place of Formation:	FLORIDA

Key Officers & Management

Name	Role	Address
EULIANO II NEIL R	Manager	3914 SW 95 DRIVE, GAINESVILLE, FL, 32608
CARNES TONY C	Manager	4438 SW 105th Drive, GAINESVILLE, FL, 32608
EULIANO II NEIL R	Agent	3914 SW 95 DRIVE, GAINESVILLE, FL, 32608

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Phone Number:

352-262-8054

E-mail Address:

tonyccarnes@gmail.com

Contact Person:

TONY CARNES

Ownership and Self-Certifications:

Self-Certified Small Disadvantaged Business

User ID:

P2110999

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:

SA73BNAHY265

CAGE Code:

7MM69

UEI Expiration Date:

2025-11-26

Business Information

Division Name:

MEDITRACE LLC

Activation Date:

2024-12-02

Initial Registration Date:

2016-05-19

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:

7MM69

Status:

Active

Type:

Non-Manufacturer

CAGE Update Date:

2024-12-02

CAGE Expiration:

2029-12-02

SAM Expiration:

2025-11-26

Contact Information

POC:

TONY C . CARNES

Events

Event Type	Filed Date	Value	Description
REGISTERED AGENT NAME CHANGED	2017-01-16	EULIANO II, NEIL R	-

Documents

Name	Date
ANNUAL REPORT	2025-01-15
ANNUAL REPORT	2024-01-29
ANNUAL REPORT	2023-01-20
ANNUAL REPORT	2022-01-24
ANNUAL REPORT	2021-01-29
ANNUAL REPORT	2020-01-17
ANNUAL REPORT	2019-01-28
ANNUAL REPORT	2018-01-17
ANNUAL REPORT	2017-01-16
Florida Limited Liability	2016-03-11

USAspending Awards / Financial Assistance

Date:

2023-09-29

Link:

View on USAspending

Awarding Agency Name:

Department of Health and Human Services

Transaction Description:

FAST-TRACK MULTIMODAL MONITORING FOR NEONATAL NEUROCRITICAL CARE - PROJECT SUMMARY IN THE US, APPROXIMATELY 1.5M BABIES ARE ADMITTED TO THE NEONATAL INTENSIVE CARE UNIT (NICU) EACH YEAR. CONTINUOUS MONITORING OF THESE PATIENTS IS ESSENTIAL AND THE ABILITY TO QUICKLY IDENTIFY CRITICAL CHANGES IN A PATIENTS' HEALTH STATUS IS CRUCIAL TO GUIDING DAILY CARE AND THERAPY. WHILE INDIVIDUAL MEDICAL DEVICES ARE HELPFUL IN THIS ENDEAVOR, INTEGRATING INFORMATION FROM MULTIPLE DEVICES ONTO ONE DISPLAY AND PERFORMING REAL-TIME ANALYTICS ON THIS DATA ENHANCES IDENTIFICATION OF THE REASONS FOR A CHANGE IN PATIENT CONDITION AND NOT JUST THAT A CONDITION HAS CHANGED. CONTINUOUSLY RECORDING AND PROVIDING BOTH TRENDING AND REAL-TIME ANALYSIS FOR REAL CHANGES IN PATIENT STATUS CAN HELP OPTIMIZE CARE DECISIONS THUS IMPROVING OUTCOMES IN THIS FRAGILE POPULATION. IN THIS GRANT WE WILL BUILD UPON THE SUCCESS OF THE PREVIOUSLY CLEARED VITAL SYNC MULTI-MODAL MONITOR THAT CAPTURES AND ANALYZES INFORMATION FROM OVER 100 DEVICES IN THE NICU TO HELP MAKE THE INFORMATION ACTIONABLE. THE NEW DEVICE PROVIDES A CONTINUOUS AND RETROSPECTIVE VIEW OF PATIENT CONDITION SO THAT CARE PROVIDERS CAN OBJECTIVELY EVALUATE THE EFFECTIVENESS OF TREATMENT MODIFICATIONS. REAL TIME ASSISTANCE WITH IDENTIFICATION OF CHANGES IN PATIENT CONDITION HELPS TO OPTIMIZE NEW NEUROPROTECTIVE PROTOCOLS. IMPROVED REVIEW OF PRIOR PATIENT CONDITION THROUGH TRENDING ANALYSIS AND EVENT MARKING ASSISTS WITH CONTINUITY OF CARE ACROSS SHIFT CHANGES. THE PHASE I PROTOTYPE IS DESIGNED TO EVALUATE THE FEASIBILITY AND USABILITY OF THE TOOL IN THE NICU ENVIRONMENT. THE PHASE 2 SYSTEM WILL SUPPORT ADDITIONAL FEATURES INCLUDING REDUCED CONNECTIVITY BURDEN AND PROTOCOL SUPPORT. CENTRAVIEW 2.0 WILL BE A PLATFORM FOR FUTURE MODULAR UPGRADES THAT WILL ENHANCE CLINICAL DECISION SUPPORT (CDS) IN ANY ICU ENVIRONMENT. PHASE 1 AIM 1 – CREATE A PROTOTYPE MULTIMODAL MONITOR FOR NEONATAL NEUROCRITICAL CARE BASED ON EXISTING EXPERIENCE AND TECHNOLOGY, WE WILL DESIGN AND PROTOTYPE A NEW GENERATION BEDSIDE MONITORING SYSTEM FOR COLLECTING AND DISPLAYING DATA FROM THE KEY NICU MEDICAL DEVICES AT UFHEALTH. PHASE 1 AIM 2 – EVALUATE USABILITY OF THE NEW SYSTEM IN A SIMULATED NICU IN A SIMULATED NICU ENVIRONMENT, WE WILL CREATE THREE NEONATAL PATIENT SCENARIOS AND EVALUATE THE SYSTEM IN A USABILITY STUDY WITH 8 NICU CLINICIANS INCLUDING SURVEYS TO DETERMINE PERCEIVED VALUE, USABILITY, AND ACCEPTANCE. PHASE 2 AIM 1 – EXPAND CONNECTIVITY, ADD PROTOCOL ADHERENCE, AND ENHANCE USABILITY CLINICAL FEEDBACK FROM A SUCCESSFUL PHASE 1 WILL BE USED TO IMPROVE THE FUNCTIONALITY AND USABILITY OF CENTRAVIEW 2. HIE PROTOCOL SUPPORT WILL BE ADDED TO THE SYSTEM ALONG WITH SEVERAL OTHER NEW FEATURES INCLUDING DERIVED PARAMETERS AND WIRELESS DATA COLLECTION. PHASE 2 – AIM 2 – EVALUATE THE EFFECTIVENESS OF CENTRAVIEW 2 CLINICAL ASSISTANT WE WILL FIRST COLLECT BASELINE DATA FOR 6 MONTHS AT UFHEALTH TO MEASURE ADHERENCE WITH SEVERAL CLINICAL PRACTICE GUIDELINES (CPG). NEXT, WE WILL INSTALL AND TRAIN CLINICIANS ON THE USE OF THE CENTRAVIEW SYSTEM AND DETERMINE IF THE SYSTEM IMPROVES COMPLIANCE WITH THE CPGS.

Obligated Amount:

1103531.00

Face Value Of Loan:

0.00

Total Face Value Of Loan: